PHARMACEUTICAL DRUG CONTAINING PYRIDYLAMINOACETIC ACID Russian patent published in 2022 - IPC A61K31/444 A61K31/5575 A61P27/06 

FIELD: medicine; pharmaceutics.

SUBSTANCE: invention relates to the field of medicine and pharmaceutics; it can be used for the treatment or prevention of primary open-angle glaucoma, secondary open-angle glaucoma, glaucoma with normal pressure or ocular hypertension in patients, for whom other treatments are not effective enough, or in whom the specified diseases are resistant to the treatment with other active ingredients, so that, when treated with other remedies for the treatment of glaucoma or ocular hypertension, a value of reduction in intraocular pressure before and after the treatment is 4.5 mmHg or less. The use of a pharmaceutical drug for the preparation of a drug for the treatment or prevention of the specified diseases is proposed, where the pharmaceutical drug contains omidenepag, its composite ester or its salt as the only active ingredient. Options are also proposed of a method for the treatment or prevention of the specified diseases by administration of a pharmaceutical drug containing omidenepag, its ester or its salt as the only active ingredient.

EFFECT: reduction in intraocular pressure is provided in patients, for whom other treatments for glaucoma or ocular hypertension are not effective enough.

19 cl, 1 dwg